Antithrombin III Deficiency
7 clinical trials · Condition
◉ Watch Antithrombin III Deficiency
| Record | Firm | Date |
|---|---|---|
| Antithrombin III in Infectious Disease Caused by COVID-19 (NCT04899232) | Enrique Ginzburg | 2021-07-06 |
| Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO (NCT04879550) | Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital | 2020-01-01 |
| Atenativ Effect on Uterine Blood Flow and Preeclampsia (NCT02278575) | Vastra Gotaland Region | 2016-01-01 |
| "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects" (NCT02503267) | Hospital Universitari Vall d'Hebron Research Institute | 2015-07-01 |
| Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate (NCT00319228) | Grifols Biologicals, LLC | 2006-01-01 |
| Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery (NCT00110513) | rEVO Biologics | 2005-04-01 |
Track Antithrombin III Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.